Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ENBIOSIS Nutra for Dry Eye
- Development stage
- Unknown
- Lead developer
- ENBIOSIS Biotechnology
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
ENBIOSIS Nutra for Dry Eye is an AI-designed, microbiome-based nutraceutical developed by ENBIOSIS Biotechnology. It is an oral functional food supplement intended to support ocular surface health by modulating the gut-eye axis. The product utilizes food-derived formulations to influence the gut microbiome and systemic host physiology, offering a supplemental approach to managing dry eye symptoms. Unlike traditional pharmaceutical interventions, it does not target specific molecular pathways but rather focuses on the holistic modulation of the microbiome. It has completed clinical trials and is currently market-ready as a functional food product.
- Brand names
- ENBIOSIS Nutra
- Other names
- ENBIOSIS Nutra - Dry Eye
Beyond the preview
Go deeper on ENBIOSIS Nutra for Dry Eye.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENBIOSIS Nutra for Dry Eye.